News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,704 Results
Type
Article (77069)
Company Profile (714)
Press Release (769895)
Multimedia
Podcasts (206)
Webinars (34)
Section
Business (228120)
Career Advice (3753)
Deals (39434)
Drug Delivery (163)
Drug Development (89632)
Employer Resources (206)
FDA (18182)
Job Trends (17227)
News (389049)
Policy (38930)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3034)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (174)
Alliances (56274)
ALS (207)
Alzheimer's disease (1885)
Antibody-drug conjugate (ADC) (417)
Approvals (18414)
Artificial intelligence (689)
Autoimmune disease (249)
Automation (52)
Bankruptcy (405)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (219)
Biotechnology (443)
Bladder cancer (185)
Brain cancer (73)
Breast cancer (727)
Cancer (5647)
Cardiovascular disease (502)
Career advice (3223)
Career pathing (46)
CAR-T (330)
CDC (71)
Celiac Disease (2)
Cell therapy (894)
Cervical cancer (43)
Clinical research (76407)
Collaboration (2086)
Company closure (6)
Compensation (1314)
Complete response letters (91)
COVID-19 (3012)
CRISPR (110)
C-suite (1055)
Cystic fibrosis (160)
Data (7251)
Decentralized trials (3)
Denatured (75)
Depression (176)
Dermatology (59)
Diabetes (591)
Diagnostics (7400)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (339)
Drug pricing (237)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (98371)
Editorial (71)
Employer branding (25)
Employer resources (174)
Events (135439)
Executive appointments (1111)
FDA (21749)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1731)
Gene editing (237)
Generative AI (68)
Gene therapy (744)
GLP-1 (1204)
Government (5451)
Grass and pollen (8)
Guidances (400)
Healthcare (20989)
HIV (81)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (327)
Immuno-oncology (92)
Indications (158)
Infectious disease (3357)
Inflammatory bowel disease (223)
Inflation Reduction Act (17)
Influenza (138)
Intellectual property (282)
Interviews (733)
IPO (17882)
IRA (61)
Job creations (4976)
Job search strategy (2605)
JPM (73)
Kidney cancer (19)
Labor market (104)
Layoffs (664)
Leadership (45)
Legal (9954)
Liver cancer (106)
Longevity (29)
Lung cancer (758)
Lymphoma (417)
Machine learning (54)
Management (66)
Manufacturing (1003)
MASH (194)
Medical device (15123)
Medtech (15206)
Mergers & acquisitions (22723)
Metabolic disorders (1589)
mRNA (215)
Multiple sclerosis (182)
NASH (24)
Neurodegenerative disease (435)
Neuropsychiatric disorders (117)
Neuroscience (3410)
Neurotech (1)
NextGen: Class of 2026 (7665)
Non-profit (5130)
Now hiring (74)
Obesity (777)
Opinion (355)
Ovarian cancer (189)
Pain (248)
Pancreatic cancer (268)
Parkinson's disease (363)
Partnered (36)
Patents (580)
Patient recruitment (620)
Peanut (65)
People (66071)
Pharmaceutical (127)
Pharmacy benefit managers (36)
Phase 1 (23665)
Phase 2 (33320)
Phase 3 (25091)
Pipeline (7322)
Policy (368)
Postmarket research (3242)
Preclinical (10396)
Press Release (72)
Prostate cancer (290)
Psychedelics (61)
Radiopharmaceuticals (330)
Rare diseases (1115)
Real estate (7207)
Recruiting (81)
Regulatory (28851)
Reports (71)
Research institute (2748)
Resumes & cover letters (585)
Rett syndrome (33)
RNA editing (22)
RSV (95)
Schizophrenia (178)
Series A (292)
Series B (214)
Service/supplier (26)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (4260)
State (2)
Stomach cancer (21)
Supply chain (128)
Tariffs (102)
The Weekly (128)
Vaccines (1229)
Venture capital (111)
Weight loss (530)
Women's health (113)
Worklife (23)
Date
Last 7 days (672)
Last 30 days (2568)
Last 365 days (32212)
2026 (8592)
2025 (32556)
2024 (37886)
2023 (42566)
2022 (53927)
2021 (58722)
2020 (57663)
2019 (51301)
2018 (39087)
2017 (36894)
2016 (37805)
2015 (43812)
2014 (38405)
2013 (34457)
2012 (36463)
2011 (36511)
2010 (35924)
Location
Africa (1212)
Alabama (99)
Alaska (7)
Arizona (352)
Arkansas (15)
Asia (50235)
Australia (8617)
California (12771)
Canada (3599)
China (1332)
Colorado (549)
Connecticut (554)
Delaware (382)
Europe (114806)
Florida (1905)
Georgia (418)
Hawaii (4)
Idaho (68)
Illinois (1059)
India (88)
Indiana (596)
Iowa (24)
Japan (505)
Kansas (137)
Kentucky (50)
Louisiana (44)
Maine (85)
Maryland (1573)
Massachusetts (9349)
Michigan (382)
Minnesota (724)
Mississippi (7)
Missouri (154)
Montana (37)
Nebraska (30)
Nevada (142)
New Hampshire (89)
New Jersey (3445)
New Mexico (33)
New York (3382)
North Carolina (1732)
North Dakota (10)
Northern California (6226)
Ohio (395)
Oklahoma (25)
Oregon (52)
Pennsylvania (2554)
Puerto Rico (27)
Rhode Island (53)
South America (1586)
South Carolina (78)
South Dakota (1)
Southern California (4985)
Tennessee (205)
Texas (2032)
United States (45871)
Utah (384)
Vermont (1)
Virginia (325)
Washington D.C. (88)
Washington State (1051)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
847,704 Results for "jiangsu yanshen biological technology stock co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics Announces Reverse Stock Split
December 30, 2025
·
3 min read
Press Releases
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
March 13, 2026
·
4 min read
Press Releases
Celldex Announces Proposed Public Offering of Common Stock
April 2, 2026
·
4 min read
Press Releases
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
January 23, 2026
·
6 min read
Rare diseases
Prasad’s Departure Could Be ‘Big Win’ for Biotech—Especially Rare Disease Space: Analysts
Some biotechs that had seen regulatory setbacks under Center for Biologics Evaluation and Research director Vinay Prasad experienced stock bumps Monday morning. Under Prasad’s leadership, the rare disease space has suffered a series of controversial rejections.
March 9, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Rad Source Technologies Announces Configurable Filters for the RS® 2000·Q2 Biological Irradiator
March 12, 2026
·
2 min read
Press Releases
Celldex Announces Pricing of $300 Million Public Offering of Common Stock
April 2, 2026
·
4 min read
Press Releases
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
March 16, 2026
·
5 min read
Press Releases
FibroBiologics Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Bid Price Requirement
March 26, 2026
·
3 min read
Press Releases
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
March 18, 2026
·
5 min read
1 of 84,771
Next
